Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel B Walter

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|April 24, 2023
H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trialsSheetal Sawant, Sarah Anne Gurley, R Glenn Overman, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Science Translational Medicine|November 5, 2020
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humansJennifer A Jenks, Cody S Nelson, Hunter K Roark, et al.
Immunity & Ageing : I & A|July 1, 2023
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trialKenneth E Schmader, Christine K Liu, Brendan Flannery, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininJames R R Whittle, Ruijun Zhang, Surender Khurana, et al.
Ebiomedicine|May 28, 2024
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoproteinCarly M Bliss, Raffael Nachbagauer, Chiara Mariottini, et al.
Clinical Pharmacokinetics|January 12, 2023
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult LifespanMarion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, et al.
Vaccine|May 14, 2013
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenarioSharon E Frey, Patricia L Winokur, Robert A Salata, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in childrenKaren L Kotloff, Natasha B Halasa, Christopher J Harrison, et al.
Vaccine|August 4, 2019
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescentsFlor M Munoz, Evan J Anderson, David I Bernstein, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|April 24, 2023
H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trialsSheetal Sawant, Sarah Anne Gurley, R Glenn Overman, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Science Translational Medicine|November 5, 2020
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humansJennifer A Jenks, Cody S Nelson, Hunter K Roark, et al.
Immunity & Ageing : I & A|July 1, 2023
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trialKenneth E Schmader, Christine K Liu, Brendan Flannery, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininJames R R Whittle, Ruijun Zhang, Surender Khurana, et al.
Ebiomedicine|May 28, 2024
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoproteinCarly M Bliss, Raffael Nachbagauer, Chiara Mariottini, et al.
Clinical Pharmacokinetics|January 12, 2023
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult LifespanMarion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, et al.
Vaccine|May 14, 2013
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenarioSharon E Frey, Patricia L Winokur, Robert A Salata, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in childrenKaren L Kotloff, Natasha B Halasa, Christopher J Harrison, et al.
Vaccine|August 4, 2019
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescentsFlor M Munoz, Evan J Anderson, David I Bernstein, et al.
Pageof 14